CDT Equity Welcomes U.S. Regulatory Development Supporting Expanded Access to Compounded Peptides
NAPLES, Fla. and CAMBRIDGE, United Kingdom, Oct. 30, 2026 (GLOBE NEWSWIRE) -- CDT Equity Inc. (Nasdaq: CDT) ("CDT" or the "Company"), today welcomed a significant development in…
MH
By Maren Holt · Senior Reporter, GLP-1
Oct 30 08:32 ETSource: FinancialContent
From the source
Read at financialcontent.comCDT Equity Welcomes U.S. Regulatory Development Supporting Expanded Access to Compounded Peptides
NAPLES, Fla. and CAMBRIDGE, United Kingdom, Oct. 30, 2026 (GLOBE NEWSWIRE) -- CDT Equity Inc. (Nasdaq: CDT) ("CDT" or the "Company"), today welcomed a significant development in the U.S. regulatory landscape for compounded peptides, which the Company believes is supportive of its strategic investment in Pep’d Inc., a U.S.-based peptide and telehealth company.
